120 results
10-K
2020 FY
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Mar 21
Annual report
4:22pm
”), and, accordingly, we depend on distributions from Topco LLC to pay our taxes and expenses, including payments under the Tax Receivable Agreement … shareholders and Maravai Life Sciences Holdings, LLC (“MLSH 1”), which may impede business decisions that could benefit our shareholders.
The Tax
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 May 21
Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance
4:21pm
not believe directly reflect our core operations. All such adjustments have been tax effected at the mid-point of an assumed statutory tax rate range of 23.0 … for such reconciliation, including net income attributable to noncontrolling interest, variations in effective tax rate, expenses to be incurred for acquisition
S-1
lrmis 7o6b6950
29 Oct 20
IPO registration
5:04pm
8-K
EX-10.2
knlsj6ks
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-99.1
iaw8kb
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
DRS
53um3bv34ll3zz
25 Mar 21
Draft registration statement
12:00am
8-K
EX-10.1
bldyc0b
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
10-Q
0ui4e
12 May 21
Quarterly report
4:26pm